Vera Therapeutics Inc (NASDAQ: VERA) is 131.86% higher on its value in year-to-date trading and has touched a low of $9.24 and a high of $50.78 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VERA stock was last observed hovering at around $37.57 in the last trading session, with the day’s loss setting it -1.91%.
Currently trading at $35.66, the stock is -6.64% and -3.34% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.63 million and changing -5.08% at the moment leaves the stock 3.12% off its SMA200. VERA registered 98.77% gain for a year compared to 6-month loss of -21.16%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -6.03% gain in the last 1 month and extending the period to 3 months gives it a -6.16%, and is -6.55% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.60% over the week and 4.90% over the month.
Vera Therapeutics Inc (VERA) has around 51 employees, a market worth around $1.96B and $0.00M in sales. Distance from 52-week low is 285.93% and -29.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.49%).
Vera Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -0.67.The EPS is expected to shrink by -13.08% this year
251.0 institutions hold shares in Vera Therapeutics Inc (VERA), with institutional investors hold 117.07% of the company’s shares. The shares outstanding are 44.45M, and float is at 41.54M with Short Float at 14.56%. Institutions hold 107.85% of the Float.
The top institutional shareholder in the company is AVORO CAPITAL ADVISORS LLC with over 4.31 million shares valued at $155.92 million. The investor’s holdings represent 8.4548 of the VERA Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 3.62 million shares valued at $130.98 million to account for 7.1022 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.34 million shares representing 6.5481 and valued at over $120.76 million, while FMR LLC holds 5.497 of the shares totaling 2.8 million with a market value of $101.37 million.
Vera Therapeutics Inc (VERA) Insider Activity
Vera Therapeutics Inc disclosed in a document filed with the SEC on Aug 28 ’24 that Fordyce Marshall (PRESIDENT AND CEO) sold a total of 30,320 shares of the company’s common stock. The trade occurred on Aug 28 ’24 and was made at $36.84 per share for $1.12 million. Following the transaction, the insider now directly holds 0.31 million shares of the VERA stock.
Still, SEC filings show that on Aug 28 ’24, MARSHALL FORDYCE (Director) Proposed Sale 30,320 shares at an average price of $37.65 for $1.14 million. The insider now directly holds shares of Vera Therapeutics Inc (VERA).
